Differentiation of murine B cells induced by chondroitin sulfate B

Cellular Immunology

Volumn 250, Issue 1-2, 2007, Pages 14-23

  Yoshihara, Ritsuko ^a   Aoyama, Eriko ^a   Kadota, Yusuke ^a   Kawai, Saeko ^a   Goto, Tomomi ^a   Zhong, Ming ^a   Gohda, Eiichi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

CD138; Chondroitin sulfate B (CSB); Differentiation; IgM; Murine B cells; Protein kinase C

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CD45RB ANTIGEN; CHONDROITIN 4 SULFATE; DERMATAN SULFATE; HEPARIN; HYALURONIC ACID; IMMUNOGLOBULIN M; INTERLEUKIN 4; INTERLEUKIN 5; SYNDECAN 1; WORTMANNIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN PRODUCTION; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DERMATAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOGLOBULIN M; INTERLEUKIN-4; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; PROTEIN KINASE C;

MURINAE;

EID: 40949158805     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.12.002     Document Type: Article

References (37)

1. Poole A.R. Proteoglycans in health and disease: structures and functions. Biochem. J. 236 (1986) 1-14
2. Hardingham T.E., and Fosang A.J. Proteoglycans: many forms and many functions. FASEB J. 6 (1992) 861-870
3. Sugahara K., Mikami T., Uyama T., Mizuguchi S., Nomura K., and Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr. Opin. Struct. Biol. 13 (2003) 612-620
4. Trowbridge J.M., and Gallo R.L. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 12 (2002) 117R-125R
5. Taylor K.R., and Gallo R.L. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20 (2006) 9-22
6. Worral J.G., Wilkinson L.S., Bayliss M.T., and Edwards J.C.W. Zonal distribution of chondroitin-4-sulfate/dermatan sulphate and chondroitin-6-sulfate in normal and diseased human synovium. Ann. Rheum. Dis. 53 (1994) 35-38
7. Castor C.W., Roberts D.J., Hossler P.A., and Bignall M.C. Connective tissue activation. XXV. Regulation of proteoglycan synthesis in human synovial cells. Arthritis Rheum. 26 (1983) 522-527
8. Kittlick P.D., Bihari-Varga M., Fischer J., Kiss N., Henzgen S., and Raabe G. Synovial membrane in rheumatoid arthritis: determination of glycosaminoglycans and age-dependent correlations. Exp. Pathol. 18 (1980) 197-203
9. Mitrovic D.R., and Darmon N. Structural and biochemical abnormalities of articular cartilage in rheumatoid arthritis. Rheumatol. Int. 10 (1990) 31-37
10. Menozzi F.D., Pethe K., Bifani P., Soncin F., Brennan M.J., and Locht C. Enhanced bacterial virulence through exploitation of host glycosaminoglycans. Mol. Microbiol. 43 (2002) 1379-1386
11. Chang X., Yamada R., and Yamamoto K. Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis. Arthritis Res. Ther. 7 (2005) R268-R273
12. Carmassi F., de Negri F., Morale M., Song K.Y., and Chung S.I. Fibrin degradation in the synovial fluid of rheumatoid arthritis patients: a model for extravascular fibrinolysis. Semin. Thromb. Hemost. 22 (1996) 489-496
13. Shin H., Nakajima T., Kitajima I., Shigeta K., Abeyama K., Imamura T., et al. Thrombin receptor-mediated synovial proliferation in patients with rheumatoid arthritis. Clin. Immunol. Immunopathol. 76 (1995) 225-233
14. Wang J.Y., and Roehrl M.H. Glycosaminoglycans are a potential cause of rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 99 (2002) 14362-14367
15. Aoyama E., Yoshihara R., Tai A., Yamamoto I., and Gohda E. PKC- and PI3K-dependent but ERK-independent proliferation of murine splenic B cells stimulated by chondroitin sulfate B. Immunol. Lett. 99 (2005) 80-84
16. Rachmilewitz J., and Tykocinski M.L. Differential effects of chondroitin sulfates A and B on monocyte and B-cell activation: evidence for B-cell activation via a CD44-dependent pathway. Blood 92 (1998) 223-229
17. Maruyama S., Kubagawa H., and Cooper M.D. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-μ antibodies. J. Immunol. 135 (1985) 192-199
18. Manjarrez-Orduño N., Moreno-García M.E., Fink K., and Santos-Argumedo L. CD138 cross-linking enhances TLR-induced B cell proliferation but decreases IgM plasma cell differentiation. Eur. J. Immunol. 37 (2007) 358-367
19. Kawamoto T., Gohda E., Iji H., Fujiwara M., and Yamamoto I. SKW 6. 4 cell differentiation induced by interleukin 6 is stimulated by butyrate. Immunopharmacology 40 (1998) 119-130
20. Sedgwick J.D., and Holt P.G. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57 (1983) 301-309
21. Hodgkin P.D., Castle B.E., and Kehry M.R. B cell differentiation induced by helper T cell membranes: evidence for sequential isotype switching and a requirement for lymphokines during proliferation. Eur. J. Immunol. 24 (1994) 239-246
22. Sanderson R.D., Lalor P., and Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1 (1989) 27-35
23. Calame K.L. Plasma cells: finding new light at the end of B cell development. Nat. Immunol. 2 (2001) 1103-1108
24. Rafi A., Nagarkatti M., and Nagarkatti P.S. Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 89 (1997) 2901-2908
25. Penc S.F., Pomahac B., Winkler T., Dorschner R.A., Eriksson E., Herndon M., and Gallo R.L. Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J. Biol. Chem. 273 (1998) 28116-28121
26. Leitges M., Schmedt C., Guinamard R., Davoust J., Schaal S., Stabel S., and Tarakhovsky A. Immunodeficiency in protein kinase Cβ-deficient mice. Science 273 (1996) 788-791
27. Suzuki H., Terauchi Y., Fujiwara M., Aizawa S., Yazaki Y., Kadowaki T., and Koyasu S. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 283 (1999) 390-392
28. Fruman D.A., Snapper S.B., Yballe C.M., Davidson L., Yu J.Y., Alt F.W., et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283 (1999) 393-397
29. Clayton E., Bardi G., Bell S.E., Chantry D., Downes C.P., Gray A., et al. A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196 (2002) 753-763
30. Horikawa K., and Takatsu K. Interleukin-5 regulates genes involved in B-cell terminal maturation. Immunology 118 (2006) 497-508
31. Rui L., Healy J.I., Blasioli J., and Goodnow C.C. ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR-driven plasma cell differentiation. J. Immunol. 177 (2006) 5337-5346
32. Guo B., and Rothstein T.L. B cell receptor (BCR) cross-talk: IL-4 creates an alternate pathway for BCR-induced ERK activation that is phosphatidylinositol 3-kinase independent. J. Immunol. 174 (2005) 5375-5381
33. Kawashima H., Hirose M., Hirose J., Nagakubo D., Plaas A.H.K., and Miyasaka M. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J. Biol. Chem. 275 (2000) 35448-35456
34. Naujokas M.F., Morin M., Anderson M.S., Peterson M., and Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74 (1993) 257-268
35. Toyama-Sorimachi N., Sorimachi H., Tobita Y., Kitamura F., Yagita H., Suzuki K., et al. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. J. Biol. Chem. 270 (1995) 7437-7444
36. Murakami S., Miyake K., June C.H., Kincade P.W., and Hodes R.J. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol. 145 (1990) 3618-3627
37. Wyant T.L., Fisher M.T., McKallip R.J., Nagarkatti P.S., Nagarkatti M., and Conrad D.H. Mouse B cell activation is inhibited by CD44 cross-linking. Immunol. Invest. 34 (2005) 399-416